One downstream signal transduction pathway for EGFR is the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin complex (mTOR) survival cascade, which is also genetically altered in the vast majority of GBM tumors [11,82]. Here, AKT1 is linked to glioblastoma.